Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0129 Transporter Info
Gene Name	SLC1A1
Transporter Name	Excitatory amino acid transporter 3
Gene ID	6505
UniProt ID	P43005

Post-Translational Modification of This DT
Overview of SLC1A1 Modification Sites with Functional and Structural Information
Sequence	M G K P A R K G C E W K R F L K N N W V L L S T V A A V V L G I T T G V L V R E H S N L S T L E K F Y F A F P G E I L M R M L K L I I L P L I I S S M I T G V A A L D S N V S G K I G L R A V V Y Y F C T T L I A V I L G I V L V V S I K P G V T Q K V G E I A R T G S T P E V S T V D A M L D L I R N M F P E N L V Q A C F Q Q Y K T K R E E V K P P S D P E M N M T E E S F T A V M T T A I S K N K T K E Y K I V G M Y S D G I N V L G L I V F C L V F G L V I G K M G E K G Q I L V D F F N A L S D A T M K I V Q I I M C Y M P L G I L F L I A G K I I E V E D W E I F R K L G L Y M A T V L T G L A I H S I V I L P L I Y F I V V R K N P F R F A M G M A Q A L L T A L M I S S S S A T L P V T F R C A E E N N Q V D K R I T R F V L P V G A T I N M D G T A L Y E A V A A V F I A Q L N D L D L G I G Q I I T I S I T A T S A S I G A A G V P Q A G L V T M V I V L S A V G L P A E D V T L I I A V D W L L D R F R T M V N V L G D A F G T G I V E K L S K K E L E Q M D V S S E V N I V N P F A L E S T I L D N E D S D T K K S Y V N G G F A V D K S D T I S F T Q T S Q F
PTM type	X-N-glycosylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	43
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC1A1 Asparagine 43 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	178
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC1A1 Asparagine 178 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC1A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	195
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC1A1 Asparagine 195 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A1			[2]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	158
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC1A1 Cystine 158 has the potential to affect its expression or activity.
Phosphorylation
Serine	9 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A1			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 137 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A1			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	476
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 476 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC1A1			[4] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	477
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 477 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC1A1			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	489
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 489 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC1A1			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	497
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 497 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC1A1			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	502
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 502 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC1A1			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	513
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 513 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC1A1			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	517
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 517 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC1A1			[3] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	522
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Serine 522 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A1			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	130
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 130 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC1A1			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	133
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 133 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC1A1			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	138
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 138 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC1A1			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	490
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 490 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC1A1			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	515
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 515 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC1A1			[4] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	519
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 519 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC1A1			[13] , [14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	521
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Threonine 521 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A1			[9] , [15]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC1A1 Tyrosine 503 has the potential to affect its expression or activity.
Ubiquitination
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC1A1			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	501
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC1A1 Lysine 501 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: EAA3_HUMAN)
2	A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3	Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
4	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
5	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
6	Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 2018 Jul;20(7):668-677.
7	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
8	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
9	Isoelectric point-based fractionation by HiRIEF coupled to LC-MS allows for in-depth quantitative analysis of the phosphoproteome. Sci Rep. 2017 Jul 3;7(1):4513.
10	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
11	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
12	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
13	Deep Coverage of Global Protein Expression and Phosphorylation in Breast Tumor Cell Lines Using TMT 10-plex Isobaric Labeling. J Proteome Res. 2017 Mar 3;16(3):1121-1132.
14	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
15	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
16	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence